share_log

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K:員工持股年度報告
美股SEC公告 ·  06/21 10:42
Moomoo AI 已提取核心訊息
Novo Nordisk A/S, a global healthcare company, has filed its annual Form 11-K report with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial statements of the Novo Nordisk Puerto Rico 401(k) Plan, which is a defined contribution plan for the company's employees in Puerto Rico. The plan's net assets available for pension benefits saw a significant increase from $6,164,237 in 2022 to $8,264,238 in 2023. The report includes unaudited financial statements such as statements of net assets and changes in net assets available for pension benefits, along with notes to the financial statements. The plan's investments, which include mutual funds, common collective trusts, and Novo Nordisk A/S common stock...Show More
Novo Nordisk A/S, a global healthcare company, has filed its annual Form 11-K report with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial statements of the Novo Nordisk Puerto Rico 401(k) Plan, which is a defined contribution plan for the company's employees in Puerto Rico. The plan's net assets available for pension benefits saw a significant increase from $6,164,237 in 2022 to $8,264,238 in 2023. The report includes unaudited financial statements such as statements of net assets and changes in net assets available for pension benefits, along with notes to the financial statements. The plan's investments, which include mutual funds, common collective trusts, and Novo Nordisk A/S common stock, are reported at fair value. The plan is exempt from the annual audit requirement due to having fewer than 100 participants and meets the conditions for an audit waiver under the Department of Labor’s Regulation. The plan's administrator is Novo Nordisk Inc., and Charles Schwab Trust Company serves as the trustee and custodian. The financial statements also note that the plan is in compliance with the Employee Retirement Income and Security Act of 1974 (ERISA) and the Puerto Rico Internal Revenue Code.
全球醫療保健公司諾和諾德已向美國證券交易委員會提交了其截至2023年12月31日的財政年度的年度11-K表格報告。該報告詳細介紹了諾和諾德波多黎各401(k)計劃的財務報表,該計劃是爲波多黎各公司員工而設立的定義貢獻計劃。計劃的淨資產可供養老金受益者使用從2022年的6164237美元增加到2023年的8264238美元。該報表包括未經審計的財務報表,如淨資產表和可供養老金受益者使用的淨資產變動表,以及財務報表註釋。計劃的投資包括共同基金、普通集合信託和諾和諾德股票,報告的公允價值。該計劃因參與人數不足100人而免於年度審計要求,並滿足勞工部法規下的審計豁免條件。該計劃的管理人是諾和諾德公司,嘉信信託公司擔任受託人和託管人。財務報表還記錄了該計劃符合1974年《僱員退休收入安全法》(ERISA)及波多黎各國內收入法規的條件。
全球醫療保健公司諾和諾德已向美國證券交易委員會提交了其截至2023年12月31日的財政年度的年度11-K表格報告。該報告詳細介紹了諾和諾德波多黎各401(k)計劃的財務報表,該計劃是爲波多黎各公司員工而設立的定義貢獻計劃。計劃的淨資產可供養老金受益者使用從2022年的6164237美元增加到2023年的8264238美元。該報表包括未經審計的財務報表,如淨資產表和可供養老金受益者使用的淨資產變動表,以及財務報表註釋。計劃的投資包括共同基金、普通集合信託和諾和諾德股票,報告的公允價值。該計劃因參與人數不足100人而免於年度審計要求,並滿足勞工部法規下的審計豁免條件。該計劃的管理人是諾和諾德公司,嘉信信託公司擔任受託人和託管人。財務報表還記錄了該計劃符合1974年《僱員退休收入安全法》(ERISA)及波多黎各國內收入法規的條件。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息